Reports

Industry Research Reports

Global Personalized Medicine (PM) Solution Market Research Report 2025

Global Personalized Medicine (PM) Solution Market Research Report 2025

Industry: Service & Software

Published Date: 2025-02-21

Pages: 120 Pages

Report ld: 4137950

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

The global market for Personalized Medicine (PM) Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Personalized Medicine (PM) Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicine (PM) Solution.

The Personalized Medicine (PM) Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Medicine (PM) Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Personalized Medicine (PM) Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

MARKET SEGMENTATION

By Company

  • 2bPrecise
  • OneOme
  • TIGAR Health- IR2Dx
  • Kailos Genetics
  • Syapse Inc
  • Karius
  • Astarte Medical
  • Fabric Genomics, INC.
  • Orion Health
  • 2B Precise
  • Fabric Genomics
  • Pfizer
  • Gene 42
  • IBM Watson Health
  • Philips Healthcare
  • Medtronic
  • Nanthealth
  • Navican
  • N-of-One
  • PierianDx
  • Sunquest Information System
  • Tempus
  • Novartis
  • Translational Software
  • Biocrates Life Sciences AG
  • Nanostring Technologies
  • Thermo Fisher Scientific
  • Quest Diagnostics Incorporated

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Personalized Diagnostics
  • Personalized Therapies
  • Personalized Nutrition & Wellness

Segment by Application

  • Oncology
  • Neurosciences
  • Immunology
  • Respiratory
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

marn_i1

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

marn_i1

Chapter 3: Detailed analysis of Personalized Medicine (PM) Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

marn_i1

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

marn_i1

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

marn_i1

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

marn_i1

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

marn_i1

Chapter 12: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Personalized Medicine (PM) Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Personalized Diagnostics

1.2.3 Personalized Therapies

1.2.4 Personalized Nutrition & Wellness

1.3 Market by Application

1.3.1 Global Personalized Medicine (PM) Solution Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Neurosciences

1.3.4 Immunology

1.3.5 Respiratory

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Global Growth Trends

2.1 Global Personalized Medicine (PM) Solution Market Perspective (2020-2031)

2.2 Global Personalized Medicine (PM) Solution Growth Trends by Region

2.2.1 Global Personalized Medicine (PM) Solution Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Personalized Medicine (PM) Solution Historic Market Size by Region (2020-2025)

2.2.3 Personalized Medicine (PM) Solution Forecasted Market Size by Region (2026-2031)

2.3 Personalized Medicine (PM) Solution Market Dynamics

2.3.1 Personalized Medicine (PM) Solution Industry Trends

2.3.2 Personalized Medicine (PM) Solution Market Drivers

2.3.3 Personalized Medicine (PM) Solution Market Challenges

2.3.4 Personalized Medicine (PM) Solution Market Restraints

muLu

3 Competition Landscape by Key Players

3.1 Global Top Personalized Medicine (PM) Solution Players by Revenue

3.1.1 Global Top Personalized Medicine (PM) Solution Players by Revenue (2020-2025)

3.1.2 Global Personalized Medicine (PM) Solution Revenue Market Share by Players (2020-2025)

3.2 Global Personalized Medicine (PM) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Personalized Medicine (PM) Solution Revenue

3.4 Global Personalized Medicine (PM) Solution Market Concentration Ratio

3.4.1 Global Personalized Medicine (PM) Solution Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine (PM) Solution Revenue in 2024

3.5 Global Key Players of Personalized Medicine (PM) Solution Head office and Area Served

3.6 Global Key Players of Personalized Medicine (PM) Solution, Product and Application

3.7 Global Key Players of Personalized Medicine (PM) Solution, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

muLu

4 Personalized Medicine (PM) Solution Breakdown Data by Type

4.1 Global Personalized Medicine (PM) Solution Historic Market Size by Type (2020-2025)

4.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Type (2026-2031)

muLu

5 Personalized Medicine (PM) Solution Breakdown Data by Application

5.1 Global Personalized Medicine (PM) Solution Historic Market Size by Application (2020-2025)

5.2 Global Personalized Medicine (PM) Solution Forecasted Market Size by Application (2026-2031)

muLu

6 North America

6.1 North America Personalized Medicine (PM) Solution Market Size (2020-2031)

6.2 North America Personalized Medicine (PM) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Personalized Medicine (PM) Solution Market Size by Country (2020-2025)

6.4 North America Personalized Medicine (PM) Solution Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

muLu

7 Europe

7.1 Europe Personalized Medicine (PM) Solution Market Size (2020-2031)

7.2 Europe Personalized Medicine (PM) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Personalized Medicine (PM) Solution Market Size by Country (2020-2025)

7.4 Europe Personalized Medicine (PM) Solution Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

muLu

8 Asia-Pacific

8.1 Asia-Pacific Personalized Medicine (PM) Solution Market Size (2020-2031)

8.2 Asia-Pacific Personalized Medicine (PM) Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2020-2025)

8.4 Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

muLu

9 Latin America

9.1 Latin America Personalized Medicine (PM) Solution Market Size (2020-2031)

9.2 Latin America Personalized Medicine (PM) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Personalized Medicine (PM) Solution Market Size by Country (2020-2025)

9.4 Latin America Personalized Medicine (PM) Solution Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

muLu

10 Middle East & Africa

10.1 Middle East & Africa Personalized Medicine (PM) Solution Market Size (2020-2031)

10.2 Middle East & Africa Personalized Medicine (PM) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2020-2025)

10.4 Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

muLu

11 Key Players Profiles

11.1 2bPrecise

11.1.1 2bPrecise Company Details

11.1.2 2bPrecise Business Overview

11.1.3 2bPrecise Personalized Medicine (PM) Solution Introduction

11.1.4 2bPrecise Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.1.5 2bPrecise Recent Development

11.2 OneOme

11.2.1 OneOme Company Details

11.2.2 OneOme Business Overview

11.2.3 OneOme Personalized Medicine (PM) Solution Introduction

11.2.4 OneOme Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.2.5 OneOme Recent Development

11.3 TIGAR Health- IR2Dx

11.3.1 TIGAR Health- IR2Dx Company Details

11.3.2 TIGAR Health- IR2Dx Business Overview

11.3.3 TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Introduction

11.3.4 TIGAR Health- IR2Dx Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.3.5 TIGAR Health- IR2Dx Recent Development

11.4 Kailos Genetics

11.4.1 Kailos Genetics Company Details

11.4.2 Kailos Genetics Business Overview

11.4.3 Kailos Genetics Personalized Medicine (PM) Solution Introduction

11.4.4 Kailos Genetics Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.4.5 Kailos Genetics Recent Development

11.5 Syapse Inc

11.5.1 Syapse Inc Company Details

11.5.2 Syapse Inc Business Overview

11.5.3 Syapse Inc Personalized Medicine (PM) Solution Introduction

11.5.4 Syapse Inc Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.5.5 Syapse Inc Recent Development

11.6 Karius

11.6.1 Karius Company Details

11.6.2 Karius Business Overview

11.6.3 Karius Personalized Medicine (PM) Solution Introduction

11.6.4 Karius Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.6.5 Karius Recent Development

11.7 Astarte Medical

11.7.1 Astarte Medical Company Details

11.7.2 Astarte Medical Business Overview

11.7.3 Astarte Medical Personalized Medicine (PM) Solution Introduction

11.7.4 Astarte Medical Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.7.5 Astarte Medical Recent Development

11.8 Fabric Genomics, INC.

11.8.1 Fabric Genomics, INC. Company Details

11.8.2 Fabric Genomics, INC. Business Overview

11.8.3 Fabric Genomics, INC. Personalized Medicine (PM) Solution Introduction

11.8.4 Fabric Genomics, INC. Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.8.5 Fabric Genomics, INC. Recent Development

11.9 Orion Health

11.9.1 Orion Health Company Details

11.9.2 Orion Health Business Overview

11.9.3 Orion Health Personalized Medicine (PM) Solution Introduction

11.9.4 Orion Health Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.9.5 Orion Health Recent Development

11.10 2B Precise

11.10.1 2B Precise Company Details

11.10.2 2B Precise Business Overview

11.10.3 2B Precise Personalized Medicine (PM) Solution Introduction

11.10.4 2B Precise Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.10.5 2B Precise Recent Development

11.11 Fabric Genomics

11.11.1 Fabric Genomics Company Details

11.11.2 Fabric Genomics Business Overview

11.11.3 Fabric Genomics Personalized Medicine (PM) Solution Introduction

11.11.4 Fabric Genomics Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.11.5 Fabric Genomics Recent Development

11.12 Pfizer

11.12.1 Pfizer Company Details

11.12.2 Pfizer Business Overview

11.12.3 Pfizer Personalized Medicine (PM) Solution Introduction

11.12.4 Pfizer Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.12.5 Pfizer Recent Development

11.13 Gene 42

11.13.1 Gene 42 Company Details

11.13.2 Gene 42 Business Overview

11.13.3 Gene 42 Personalized Medicine (PM) Solution Introduction

11.13.4 Gene 42 Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.13.5 Gene 42 Recent Development

11.14 IBM Watson Health

11.14.1 IBM Watson Health Company Details

11.14.2 IBM Watson Health Business Overview

11.14.3 IBM Watson Health Personalized Medicine (PM) Solution Introduction

11.14.4 IBM Watson Health Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.14.5 IBM Watson Health Recent Development

11.15 Philips Healthcare

11.15.1 Philips Healthcare Company Details

11.15.2 Philips Healthcare Business Overview

11.15.3 Philips Healthcare Personalized Medicine (PM) Solution Introduction

11.15.4 Philips Healthcare Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.15.5 Philips Healthcare Recent Development

11.16 Medtronic

11.16.1 Medtronic Company Details

11.16.2 Medtronic Business Overview

11.16.3 Medtronic Personalized Medicine (PM) Solution Introduction

11.16.4 Medtronic Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.16.5 Medtronic Recent Development

11.17 Nanthealth

11.17.1 Nanthealth Company Details

11.17.2 Nanthealth Business Overview

11.17.3 Nanthealth Personalized Medicine (PM) Solution Introduction

11.17.4 Nanthealth Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.17.5 Nanthealth Recent Development

11.18 Navican

11.18.1 Navican Company Details

11.18.2 Navican Business Overview

11.18.3 Navican Personalized Medicine (PM) Solution Introduction

11.18.4 Navican Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.18.5 Navican Recent Development

11.19 N-of-One

11.19.1 N-of-One Company Details

11.19.2 N-of-One Business Overview

11.19.3 N-of-One Personalized Medicine (PM) Solution Introduction

11.19.4 N-of-One Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.19.5 N-of-One Recent Development

11.20 PierianDx

11.20.1 PierianDx Company Details

11.20.2 PierianDx Business Overview

11.20.3 PierianDx Personalized Medicine (PM) Solution Introduction

11.20.4 PierianDx Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.20.5 PierianDx Recent Development

11.21 Sunquest Information System

11.21.1 Sunquest Information System Company Details

11.21.2 Sunquest Information System Business Overview

11.21.3 Sunquest Information System Personalized Medicine (PM) Solution Introduction

11.21.4 Sunquest Information System Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.21.5 Sunquest Information System Recent Development

11.22 Tempus

11.22.1 Tempus Company Details

11.22.2 Tempus Business Overview

11.22.3 Tempus Personalized Medicine (PM) Solution Introduction

11.22.4 Tempus Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.22.5 Tempus Recent Development

11.23 Novartis

11.23.1 Novartis Company Details

11.23.2 Novartis Business Overview

11.23.3 Novartis Personalized Medicine (PM) Solution Introduction

11.23.4 Novartis Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.23.5 Novartis Recent Development

11.24 Translational Software

11.24.1 Translational Software Company Details

11.24.2 Translational Software Business Overview

11.24.3 Translational Software Personalized Medicine (PM) Solution Introduction

11.24.4 Translational Software Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.24.5 Translational Software Recent Development

11.25 Biocrates Life Sciences AG

11.25.1 Biocrates Life Sciences AG Company Details

11.25.2 Biocrates Life Sciences AG Business Overview

11.25.3 Biocrates Life Sciences AG Personalized Medicine (PM) Solution Introduction

11.25.4 Biocrates Life Sciences AG Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.25.5 Biocrates Life Sciences AG Recent Development

11.26 Nanostring Technologies

11.26.1 Nanostring Technologies Company Details

11.26.2 Nanostring Technologies Business Overview

11.26.3 Nanostring Technologies Personalized Medicine (PM) Solution Introduction

11.26.4 Nanostring Technologies Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.26.5 Nanostring Technologies Recent Development

11.27 Thermo Fisher Scientific

11.27.1 Thermo Fisher Scientific Company Details

11.27.2 Thermo Fisher Scientific Business Overview

11.27.3 Thermo Fisher Scientific Personalized Medicine (PM) Solution Introduction

11.27.4 Thermo Fisher Scientific Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.27.5 Thermo Fisher Scientific Recent Development

11.28 Quest Diagnostics Incorporated

11.28.1 Quest Diagnostics Incorporated Company Details

11.28.2 Quest Diagnostics Incorporated Business Overview

11.28.3 Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Introduction

11.28.4 Quest Diagnostics Incorporated Revenue in Personalized Medicine (PM) Solution Business (2020-2025)

11.28.5 Quest Diagnostics Incorporated Recent Development

muLu

12 Analyst's Viewpoints/Conclusions

muLu

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global Personalized Medicine (PM) Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Personalized Diagnostics
Table 3. Key Players of Personalized Therapies
Table 4. Key Players of Personalized Nutrition & Wellness
Table 5. Global Personalized Medicine (PM) Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Personalized Medicine (PM) Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Personalized Medicine (PM) Solution Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Personalized Medicine (PM) Solution Market Share by Region (2020-2025)
Table 9. Global Personalized Medicine (PM) Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Personalized Medicine (PM) Solution Market Share by Region (2026-2031)
Table 11. Personalized Medicine (PM) Solution Market Trends
Table 12. Personalized Medicine (PM) Solution Market Drivers
Table 13. Personalized Medicine (PM) Solution Market Challenges
Table 14. Personalized Medicine (PM) Solution Market Restraints
Table 15. Global Personalized Medicine (PM) Solution Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Personalized Medicine (PM) Solution Market Share by Players (2020-2025)
Table 17. Global Top Personalized Medicine (PM) Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine (PM) Solution as of 2024)
Table 18. Ranking of Global Top Personalized Medicine (PM) Solution Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Personalized Medicine (PM) Solution Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Personalized Medicine (PM) Solution, Headquarters and Area Served
Table 21. Global Key Players of Personalized Medicine (PM) Solution, Product and Application
Table 22. Global Key Players of Personalized Medicine (PM) Solution, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Personalized Medicine (PM) Solution Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Personalized Medicine (PM) Solution Revenue Market Share by Type (2020-2025)
Table 26. Global Personalized Medicine (PM) Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Personalized Medicine (PM) Solution Revenue Market Share by Type (2026-2031)
Table 28. Global Personalized Medicine (PM) Solution Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Personalized Medicine (PM) Solution Revenue Market Share by Application (2020-2025)
Table 30. Global Personalized Medicine (PM) Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Personalized Medicine (PM) Solution Revenue Market Share by Application (2026-2031)
Table 32. North America Personalized Medicine (PM) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Personalized Medicine (PM) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Personalized Medicine (PM) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Personalized Medicine (PM) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Personalized Medicine (PM) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Personalized Medicine (PM) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Personalized Medicine (PM) Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Personalized Medicine (PM) Solution Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Personalized Medicine (PM) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Personalized Medicine (PM) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Personalized Medicine (PM) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Personalized Medicine (PM) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Personalized Medicine (PM) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 47. 2bPrecise Company Details
Table 48. 2bPrecise Business Overview
Table 49. 2bPrecise Personalized Medicine (PM) Solution Product
Table 50. 2bPrecise Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 51. 2bPrecise Recent Development
Table 52. OneOme Company Details
Table 53. OneOme Business Overview
Table 54. OneOme Personalized Medicine (PM) Solution Product
Table 55. OneOme Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 56. OneOme Recent Development
Table 57. TIGAR Health- IR2Dx Company Details
Table 58. TIGAR Health- IR2Dx Business Overview
Table 59. TIGAR Health- IR2Dx Personalized Medicine (PM) Solution Product
Table 60. TIGAR Health- IR2Dx Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 61. TIGAR Health- IR2Dx Recent Development
Table 62. Kailos Genetics Company Details
Table 63. Kailos Genetics Business Overview
Table 64. Kailos Genetics Personalized Medicine (PM) Solution Product
Table 65. Kailos Genetics Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 66. Kailos Genetics Recent Development
Table 67. Syapse Inc Company Details
Table 68. Syapse Inc Business Overview
Table 69. Syapse Inc Personalized Medicine (PM) Solution Product
Table 70. Syapse Inc Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 71. Syapse Inc Recent Development
Table 72. Karius Company Details
Table 73. Karius Business Overview
Table 74. Karius Personalized Medicine (PM) Solution Product
Table 75. Karius Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 76. Karius Recent Development
Table 77. Astarte Medical Company Details
Table 78. Astarte Medical Business Overview
Table 79. Astarte Medical Personalized Medicine (PM) Solution Product
Table 80. Astarte Medical Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 81. Astarte Medical Recent Development
Table 82. Fabric Genomics, INC. Company Details
Table 83. Fabric Genomics, INC. Business Overview
Table 84. Fabric Genomics, INC. Personalized Medicine (PM) Solution Product
Table 85. Fabric Genomics, INC. Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 86. Fabric Genomics, INC. Recent Development
Table 87. Orion Health Company Details
Table 88. Orion Health Business Overview
Table 89. Orion Health Personalized Medicine (PM) Solution Product
Table 90. Orion Health Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 91. Orion Health Recent Development
Table 92. 2B Precise Company Details
Table 93. 2B Precise Business Overview
Table 94. 2B Precise Personalized Medicine (PM) Solution Product
Table 95. 2B Precise Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 96. 2B Precise Recent Development
Table 97. Fabric Genomics Company Details
Table 98. Fabric Genomics Business Overview
Table 99. Fabric Genomics Personalized Medicine (PM) Solution Product
Table 100. Fabric Genomics Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 101. Fabric Genomics Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Personalized Medicine (PM) Solution Product
Table 105. Pfizer Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 106. Pfizer Recent Development
Table 107. Gene 42 Company Details
Table 108. Gene 42 Business Overview
Table 109. Gene 42 Personalized Medicine (PM) Solution Product
Table 110. Gene 42 Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 111. Gene 42 Recent Development
Table 112. IBM Watson Health Company Details
Table 113. IBM Watson Health Business Overview
Table 114. IBM Watson Health Personalized Medicine (PM) Solution Product
Table 115. IBM Watson Health Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 116. IBM Watson Health Recent Development
Table 117. Philips Healthcare Company Details
Table 118. Philips Healthcare Business Overview
Table 119. Philips Healthcare Personalized Medicine (PM) Solution Product
Table 120. Philips Healthcare Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 121. Philips Healthcare Recent Development
Table 122. Medtronic Company Details
Table 123. Medtronic Business Overview
Table 124. Medtronic Personalized Medicine (PM) Solution Product
Table 125. Medtronic Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 126. Medtronic Recent Development
Table 127. Nanthealth Company Details
Table 128. Nanthealth Business Overview
Table 129. Nanthealth Personalized Medicine (PM) Solution Product
Table 130. Nanthealth Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 131. Nanthealth Recent Development
Table 132. Navican Company Details
Table 133. Navican Business Overview
Table 134. Navican Personalized Medicine (PM) Solution Product
Table 135. Navican Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 136. Navican Recent Development
Table 137. N-of-One Company Details
Table 138. N-of-One Business Overview
Table 139. N-of-One Personalized Medicine (PM) Solution Product
Table 140. N-of-One Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 141. N-of-One Recent Development
Table 142. PierianDx Company Details
Table 143. PierianDx Business Overview
Table 144. PierianDx Personalized Medicine (PM) Solution Product
Table 145. PierianDx Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 146. PierianDx Recent Development
Table 147. Sunquest Information System Company Details
Table 148. Sunquest Information System Business Overview
Table 149. Sunquest Information System Personalized Medicine (PM) Solution Product
Table 150. Sunquest Information System Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 151. Sunquest Information System Recent Development
Table 152. Tempus Company Details
Table 153. Tempus Business Overview
Table 154. Tempus Personalized Medicine (PM) Solution Product
Table 155. Tempus Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 156. Tempus Recent Development
Table 157. Novartis Company Details
Table 158. Novartis Business Overview
Table 159. Novartis Personalized Medicine (PM) Solution Product
Table 160. Novartis Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 161. Novartis Recent Development
Table 162. Translational Software Company Details
Table 163. Translational Software Business Overview
Table 164. Translational Software Personalized Medicine (PM) Solution Product
Table 165. Translational Software Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 166. Translational Software Recent Development
Table 167. Biocrates Life Sciences AG Company Details
Table 168. Biocrates Life Sciences AG Business Overview
Table 169. Biocrates Life Sciences AG Personalized Medicine (PM) Solution Product
Table 170. Biocrates Life Sciences AG Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 171. Biocrates Life Sciences AG Recent Development
Table 172. Nanostring Technologies Company Details
Table 173. Nanostring Technologies Business Overview
Table 174. Nanostring Technologies Personalized Medicine (PM) Solution Product
Table 175. Nanostring Technologies Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 176. Nanostring Technologies Recent Development
Table 177. Thermo Fisher Scientific Company Details
Table 178. Thermo Fisher Scientific Business Overview
Table 179. Thermo Fisher Scientific Personalized Medicine (PM) Solution Product
Table 180. Thermo Fisher Scientific Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 181. Thermo Fisher Scientific Recent Development
Table 182. Quest Diagnostics Incorporated Company Details
Table 183. Quest Diagnostics Incorporated Business Overview
Table 184. Quest Diagnostics Incorporated Personalized Medicine (PM) Solution Product
Table 185. Quest Diagnostics Incorporated Revenue in Personalized Medicine (PM) Solution Business (2020-2025) & (US$ Million)
Table 186. Quest Diagnostics Incorporated Recent Development
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
Table 190. Authors List of This Report
muLu

List of Figures

Figure 1. Personalized Medicine (PM) Solution Picture
Figure 2. Global Personalized Medicine (PM) Solution Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Personalized Medicine (PM) Solution Market Share by Type: 2024 VS 2031
Figure 4. Personalized Diagnostics Features
Figure 5. Personalized Therapies Features
Figure 6. Personalized Nutrition & Wellness Features
Figure 7. Global Personalized Medicine (PM) Solution Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Personalized Medicine (PM) Solution Market Share by Application: 2024 VS 2031
Figure 9. Oncology Case Studies
Figure 10. Neurosciences Case Studies
Figure 11. Immunology Case Studies
Figure 12. Respiratory Case Studies
Figure 13. Others Case Studies
Figure 14. Personalized Medicine (PM) Solution Report Years Considered
Figure 15. Global Personalized Medicine (PM) Solution Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Personalized Medicine (PM) Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Personalized Medicine (PM) Solution Market Share by Region: 2024 VS 2031
Figure 18. Global Personalized Medicine (PM) Solution Market Share by Players in 2024
Figure 19. Global Top Personalized Medicine (PM) Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicine (PM) Solution as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Personalized Medicine (PM) Solution Revenue in 2024
Figure 21. North America Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Personalized Medicine (PM) Solution Market Share by Country (2020-2031)
Figure 23. United States Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Personalized Medicine (PM) Solution Market Share by Country (2020-2031)
Figure 27. Germany Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Personalized Medicine (PM) Solution Market Share by Region (2020-2031)
Figure 35. China Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Personalized Medicine (PM) Solution Market Share by Country (2020-2031)
Figure 43. Mexico Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Personalized Medicine (PM) Solution Market Share by Country (2020-2031)
Figure 47. Turkey Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Personalized Medicine (PM) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. 2bPrecise Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 51. OneOme Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 52. TIGAR Health- IR2Dx Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 53. Kailos Genetics Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 54. Syapse Inc Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 55. Karius Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 56. Astarte Medical Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 57. Fabric Genomics, INC. Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 58. Orion Health Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 59. 2B Precise Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 60. Fabric Genomics Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 61. Pfizer Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 62. Gene 42 Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 63. IBM Watson Health Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 64. Philips Healthcare Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 65. Medtronic Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 66. Nanthealth Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 67. Navican Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 68. N-of-One Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 69. PierianDx Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 70. Sunquest Information System Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 71. Tempus Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 72. Novartis Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 73. Translational Software Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 74. Biocrates Life Sciences AG Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 75. Nanostring Technologies Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 76. Thermo Fisher Scientific Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 77. Quest Diagnostics Incorporated Revenue Growth Rate in Personalized Medicine (PM) Solution Business (2020-2025)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Personalized Medicine (PM) Solution market?zhanKai
The top companies in the global Personalized Medicine (PM) Solution market are 2bPrecise、OneOme、TIGAR Health- IR2Dx.
den_biaoTiZhungShi

Related Reports

Global Personalized Medicine (PM) Solution Market Research Report 2025

Industry: Service & Software

Published Date: 2025-02-21

Pages: 120 Pages

Report ld: 4137950

CHOOSE LICENSE TYPE
tip

USD 2900.00

tip

USD 4350.00

tip

USD 5800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Online

TANG XIN

Japanese,English

Offline

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Offline

YUJIE TIAN

Chinese, English

Offline

DAMON

Chinese, English

Offline

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now